Stephan Blechinger

Tenecteplase versus standard of care for minor ischaemic stroke with proven occlusion (TEMPO-2): a randomised, open label, phase 3 superiority trial

Shelagh B. Coutts, Sandeep Ankolekar, Ramana Appireddy et al. · The Lancet · 2024 · 125 citations · Full text

Medicine, Neurology, Cerebrovascular Surgery +11

Epidemiology of Multiple Sclerosis in Austria

Sabine Salhofer‐Polanyi, Hakan Çetin, Fritz Leutmezer et al. · Neuroepidemiology · 2017 · 31 citations

Veterinary Medicine, Neurology, Clinical Epidemiology +15

Therapeutic plasma exchange in steroid-refractory multiple sclerosis relapses. A retrospective two-center study

Stephan Blechinger, Johannes Ehler, Gabriel Bsteh et al. · Therapeutic Advances in Neurological Disorders · 2021 · 27 citations · Full text

Medicine, Neurology, Disability Management +13

Treatment of the First Acute Relapse Following Therapeutic Plasma Exchange in Formerly Glucocorticosteroid-Unresponsive Multiple Sclerosis Patients—A Multicenter Study to Evaluate Glucocorticosteroid Responsiveness

Johannes Ehler, Stephan Blechinger, Paulus Rommer et al. · International Journal of Molecular Sciences · 2017 · 14 citations · Full text

Pharmacy, Neurology, Pharmacotherapy +14